Blue Jet Healthcare IPO: All You Need To Know

Blue Jet Healthcare Ltd. will launch its initial public offering on Oct. 25. The speciality pharmaceutical and healthcare ingredients and intermediates company plans to raise Rs 840.3 crore via an offer for sale.

The offer for sale of 2.42 crore shares will be sold in the fixed price band of Rs 329 to Rs 346 per share. The IPO issue closes on Oct. 27

The company will not receive any proceeds from this offer, and all offer proceeds will be go to the selling shareholders.

• Anchor investor bidding date: Oct. 23.

• Issue opens: Oct. 25.

• Issue closes: Oct. 27.

• Total issue size: 2.42 crore shares.

• Offer for sale size: 2.42 crore shares.

• Total issue: Rs 840.3 crore.

• Price band: Rs 329–346 per share.

Blue Jet Healthcare is a speciality pharmaceutical and healthcare ingredients and intermediates company, offering niche products targeted towards innovator pharmaceutical companies and multi-national generic pharmaceutical companies.

The company's operations are primarily organised in three product categories:

• Contrast media intermediates.

• High-intensity sweeteners.

• Pharma intermediates and active pharmaceutical ingredients.

• Dependent on Europe and the United States, which are regulated markets, for a significant portion of the revenue from operations.

• If the company is not able to commercialise new products in a timely manner, its business will be affected.

• The company's inability to successfully expand its production capacity could have an adverse effect on the business.

• A slowdown or shutdown in the company's manufacturing operations could have an adverse impact on the business.

• Any manufacturing or quality control problems may subject the company to regulatory action or litigation.

• The company is exposed to counterparty credit risk, and any delay in receiving payments or non-receipt of payments may adversely impact the results of operations.